483
Cipla, Ltd.Cipla, Ltd. – FDA 483, Mar 20, 2019
Record Details
This FDA Form 483 report details significant deficiencies at Cipla Ltd., a manufacturer of Active Pharmaceutical Ingredients and finished drug products. Observations highlight an ineffective quality management system, inadequate investigations, insufficient employee training, and a lack of process validation and control for critical manufacturing processes. The findings indicate a systemic failure to ensure product quality and consistency.
View Company Profile
ID · 4f536fa1-9193-4e02-8c65-9f726b4bc1da
Other documents for Cipla, Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.